Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
November 16, 2021
0Patent Application Number
163341310
Date Filed
September 20, 2017
0Patent Primary Examiner
Patent abstract
The present disclosure relates to use of heparin analogues as inhibitors of proprotein convertase subtilisin-like/kexin type 9 (PCSK9) for the treatment of lipoprotein metabolism disorders.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
